Anand Mahadevan

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. doi request reprint The RSSearchâ„¢ Registry: patterns of care and outcomes research on patients treated with stereotactic radiosurgery and stereotactic body radiotherapy
    Joanne N Davis
    Department of Radiation Oncology, Beth Israel Deaconness Medical Center, Harvard Medical School, Boston, MA, USA
    Radiat Oncol 8:275. 2013
  2. doi request reprint Stereotactic body radiotherapy reirradiation for recurrent epidural spinal metastases
    Anand Mahadevan
    Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA
    Int J Radiat Oncol Biol Phys 81:1500-5. 2011
  3. doi request reprint Clinical outcome after hypofractionated stereotactic radiotherapy (HSRT) for benign skull base tumors
    Anand Mahadevan
    Department of Radiation Oncology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, MA 02445, USA
    Comput Aided Surg 16:112-20. 2011
  4. doi request reprint Induction gemcitabine and stereotactic body radiotherapy for locally advanced nonmetastatic pancreas cancer
    Anand Mahadevan
    Department of Radiation Oncology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215, USA
    Int J Radiat Oncol Biol Phys 81:e615-22. 2011
  5. doi request reprint Stereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancer
    Anand Mahadevan
    Department of Radiation Oncology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA
    Int J Radiat Oncol Biol Phys 78:735-42. 2010
  6. ncbi request reprint Concurrent weekly docetaxel and concomitant boost radiation therapy in the treatment of locally advanced squamous cell cancer of the head and neck
    Roy B Tishler
    Department of Radiation Oncology, Dana Farber Cancer Institute, Brigham and Women s Hospital, Boston, MA 02115, USA
    Int J Radiat Oncol Biol Phys 65:1036-44. 2006
  7. doi request reprint Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer
    Robert Haddad
    Head and Neck Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA
    Cancer 115:4514-23. 2009
  8. ncbi request reprint Induction chemotherapy in locally advanced squamous cell cancer of the head and neck: evolution of the sequential treatment approach
    Marshall R Posner
    Department of Medical Oncology, Dana Farber Cancer Institute, SW 430, 44 Binney Street, Boston, MA 02115, USA
    Semin Oncol 31:778-85. 2004
  9. ncbi request reprint Long term survival with adjuvant carboplatin, paclitaxel, and radiation therapy in anaplastic thyroid cancer
    Robert Haddad
    Dana Farber Cancer Institute, Boston, MA 02115, USA
    Am J Clin Oncol 28:104. 2005
  10. pmc Hypofractionated Radiotherapy and Stereotactic Boost with Concurrent and Adjuvant Temozolamide for Glioblastoma in Good Performance Status Elderly Patients - Early Results of a Phase II Trial
    Scott R Floyd
    Beth Israel Deaconess Medical Center Boston, MA, USA Harvard Medical School Boston, MA, USA
    Front Oncol 2:122. 2012

Collaborators

Detail Information

Publications19

  1. doi request reprint The RSSearchâ„¢ Registry: patterns of care and outcomes research on patients treated with stereotactic radiosurgery and stereotactic body radiotherapy
    Joanne N Davis
    Department of Radiation Oncology, Beth Israel Deaconness Medical Center, Harvard Medical School, Boston, MA, USA
    Radiat Oncol 8:275. 2013
    ..Illustrative patient-related outcomes are also presented for two common treatment sites - brain metastases and liver metastases...
  2. doi request reprint Stereotactic body radiotherapy reirradiation for recurrent epidural spinal metastases
    Anand Mahadevan
    Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA
    Int J Radiat Oncol Biol Phys 81:1500-5. 2011
    ..We report the use of SBRT for 60 consecutive patients (81 lesions) who had radiological progressive spine metastasis with epidural involvement after previous radiation for spine metastasis...
  3. doi request reprint Clinical outcome after hypofractionated stereotactic radiotherapy (HSRT) for benign skull base tumors
    Anand Mahadevan
    Department of Radiation Oncology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, MA 02445, USA
    Comput Aided Surg 16:112-20. 2011
    ..The objective of this study was to assess the neurological outcome, local control rate and morbidity associated with a 5-fraction regime of hypofractionated stereotactic radiotherapy (HSRT) for benign skull base tumors...
  4. doi request reprint Induction gemcitabine and stereotactic body radiotherapy for locally advanced nonmetastatic pancreas cancer
    Anand Mahadevan
    Department of Radiation Oncology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215, USA
    Int J Radiat Oncol Biol Phys 81:e615-22. 2011
    ..We therefore retrospectively analyzed a planned strategy of initial chemotherapy with restaging and then treatment for those patients with no evidence of metastatic progression with SBRT...
  5. doi request reprint Stereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancer
    Anand Mahadevan
    Department of Radiation Oncology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02215, USA
    Int J Radiat Oncol Biol Phys 78:735-42. 2010
    ..We explored the safety and effectiveness of a 3-day course of hypofractionated stereotactic body radiotherapy (SBRT) followed by gemcitabine in this population...
  6. ncbi request reprint Concurrent weekly docetaxel and concomitant boost radiation therapy in the treatment of locally advanced squamous cell cancer of the head and neck
    Roy B Tishler
    Department of Radiation Oncology, Dana Farber Cancer Institute, Brigham and Women s Hospital, Boston, MA 02115, USA
    Int J Radiat Oncol Biol Phys 65:1036-44. 2006
    ..In a Phase I/II trial, we investigated concurrent weekly docetaxel and concomitant boost radiation in patients with locally advanced squamous cell cancer of the head and neck (SCCHN) after induction chemotherapy...
  7. doi request reprint Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer
    Robert Haddad
    Head and Neck Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA
    Cancer 115:4514-23. 2009
    ....
  8. ncbi request reprint Induction chemotherapy in locally advanced squamous cell cancer of the head and neck: evolution of the sequential treatment approach
    Marshall R Posner
    Department of Medical Oncology, Dana Farber Cancer Institute, SW 430, 44 Binney Street, Boston, MA 02115, USA
    Semin Oncol 31:778-85. 2004
    ..ST may represent the cutting edge of therapy for patients with curable, locally advanced SCCHN...
  9. ncbi request reprint Long term survival with adjuvant carboplatin, paclitaxel, and radiation therapy in anaplastic thyroid cancer
    Robert Haddad
    Dana Farber Cancer Institute, Boston, MA 02115, USA
    Am J Clin Oncol 28:104. 2005
  10. pmc Hypofractionated Radiotherapy and Stereotactic Boost with Concurrent and Adjuvant Temozolamide for Glioblastoma in Good Performance Status Elderly Patients - Early Results of a Phase II Trial
    Scott R Floyd
    Beth Israel Deaconess Medical Center Boston, MA, USA Harvard Medical School Boston, MA, USA
    Front Oncol 2:122. 2012
    ..There was no additional toxicity. These results indicate that elderly patients with good KPS can achieve outcomes comparable to the current standard of care using an abbreviated radiotherapy course, radiosurgery boost, and temozolomide...
  11. doi request reprint Organ deformation and dose coverage in robotic respiratory-tracking radiotherapy
    Xing Qi Lu
    Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
    Int J Radiat Oncol Biol Phys 71:281-9. 2008
    ..However, the effect of deformation, defined as any changes in the body and organs relative to the center of fiducials, remains unanswered. This study investigated this problem and a possible solution...
  12. doi request reprint Frameless angiogram-based stereotactic radiosurgery for treatment of arteriovenous malformations
    Xing Qi Lu
    Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA
    Int J Radiat Oncol Biol Phys 84:274-82. 2012
    ..Without DSA as the primary image, target definition may be less than optimal, in some cases precluding the ability to treat with a frameless system. This article reports a novel solution...
  13. doi request reprint Melanoma brain metastasis: overview of current management and emerging targeted therapies
    Ekokobe Fonkem
    Brain Tumor Center and Neuro Oncology Unit, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA
    Expert Rev Neurother 12:1207-15. 2012
    ..Additional clinical trials of newer agents involving these pathways are also showing promise. Therefore, targeted therapies must be incorporated into the multimodality management of melanoma brain metastasis...
  14. doi request reprint Spectral CT with metal artifacts reduction software for improvement of tumor visibility in the vicinity of gold fiducial markers
    Olga R Brook
    Department of Radiology, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Boston, MA, 02215, USA
    Radiology 263:696-705. 2012
    ..To evaluate spectral computed tomography (CT) with metal artifacts reduction software (MARS) for reduction of metal artifacts associated with gold fiducial seeds...
  15. ncbi request reprint Definitive radiotherapy with interstitial implant boost for squamous cell carcinoma of the tongue base
    Omur Karakoyun-Celik
    Department of Radiation Oncology, Massachusetts General Hospital, 100 Blossom Street, Cox 3, Boston, MA 02114, USA
    Head Neck 27:353-61. 2005
    ..The purpose of this study was to examine the long-term outcome of a cohort of patients with unresected base of tongue carcinoma who received interstitial brachytherapy after comprehensive external beam radiation therapy...
  16. ncbi request reprint Cyberknife radiosurgery for basal skull plasmacytoma
    Eric T Wong
    Brain Tumor Center and Neuro Oncology Unit, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA
    J Neuroimaging 16:361-3. 2006
    ..To our knowledge, this is a first case of successful Cyberknife radiosurgery of a medullary plasmacytoma...
  17. pmc "Hitting all the right markers to save a life" Solitary fibrous tumors of the central nervous system: Case series and review of the literature
    Ekkehard Kasper
    Division of Neurosurgery, Beth Israel Deaconess Medical Centre, Harvard University, Boston, Massachusetts, USA
    Surg Neurol Int 3:83. 2012
    ..For this reason, we present two cases of large SFTs to illustrate a comprehensive review...
  18. doi request reprint Safety profile and technical success of imaging-guided percutaneous fiducial seed placement with and without core biopsy in the abdomen and pelvis
    Olga R Brook
    Department of Radiology, Beth Israel Deaconess Medical Center, 330 Brookline Ave, Boston, MA 02215, USA
    AJR Am J Roentgenol 198:466-70. 2012
    ....
  19. ncbi request reprint Docetaxel, cisplatin, 5-fluorouracil (TPF)-based induction chemotherapy for head and neck cancer and the case for sequential, combined-modality treatment
    Robert Haddad
    Department of Adult Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
    Oncologist 8:35-44. 2003
    ....